Stocks and Investing Stocks and Investing
Wed, September 11, 2024
Tue, September 10, 2024

Douglas Tsao Reiterated (VRDN) at Strong Buy and Held Target at $27 on, Sep 10th, 2024


Published on 2024-10-28 14:10:57 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $27 on, Sep 10th, 2024.

Douglas has made no other calls on VRDN in the last 4 months.



There are 6 other peers that have a rating on VRDN. Out of the 6 peers that are also analyzing VRDN, 0 agree with Douglas's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Douglas


  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $30 on, Friday, August 30th, 2024
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $35 on, Wednesday, August 28th, 2024
  • Leland Gershell of "Oppenheimer" Reiterated at Buy with Decreased Target to $28 on, Monday, August 12th, 2024
  • Laura Chico of "Wedbush" Reiterated at Buy and Held Target at $42 on, Monday, July 29th, 2024
  • Andy Chen of "Wolfe Research" Initiated at Buy on, Tuesday, June 11th, 2024
  • Richard Law of "Goldman Sachs" Initiated at Strong Buy and Held Target at $23 on, Thursday, June 6th, 2024
Contributing Sources